Back to User profile » Dr Cynthia Besch-Williford

Paper published by Dr Cynthia Besch-Williford:


Original Research

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM

Breast Cancer: Targets and Therapy 2018, 10:53-67

Published Date: 22 March 2018